Gores X

The filing definitively anchors the trust account balance at $358,800,000, providing the precise numerical foundation for all future per-share redemption valuations and liquidation distribution models. By fixing the May 5, 2025 IPO date and a 24-to-27-month completion window, it establishes the hard expiration boundary for the SPAC's search phase, directly governing redemption calendar tracking. As the company explicitly states it had not commenced any operations as of May 5, 2025, generated zero operating revenues, and carries an accumulated deficit of $(23,604,580), the filing confirms the absence of any identifiable target, customer relationships, revenue streams, technology assets, or strategic partnerships to evaluate. The sponsor's contractual waiver of liquidation rights on founder and private placement shares, paired with the underwriters' waiver of deferred commissions in a failure scenario, structurally limits downside dilution for public investors. Conversely, the heavy reliance on deferred underwriting and advisory payouts, combined with the $20,000 monthly operational burn, introduces ongoing capital efficiency risks that will compound as the regulatory extension deadline approaches.

This filing establishes the baseline trust value ($10.00 per share) and the deadline for the business combination. The full exercise of the over-allotment and the sponsor's private placement increase the cash available for a deal. The lock-up periods and waiver of redemption rights by insiders are standard but important for assessing sponsor alignment. The trust can only be used for a business combination, redemptions upon charter amendments, or liquidation; interest income may be released for working capital and taxes under specified limits.

This establishes the trust value ($312M, $10.42 per share as of filing), the deadline (2027-05-05 for a 24-month target, extended to 2027-08-05 if a definitive agreement is reached), and the redemption mechanics. The sponsor's low-cost founder shares ($0.003) create misaligned incentives. The SPAC has no target and a track record of liquidated prior SPACs (Gores Holdings VII, VIII, IX, Technology I & II). Current interest income is available to fund working capital (up to $600k/yr), and the sponsor can convert up to $1.5M in working capital loans into equity at $10.00/share.

This exhibits-only compilation fixes the structural and contractual parameters that govern post-IPO capital allocation, warrant dilution, and underwriting compensation. Alec Gores certifies in the attached director’s certificate that the authorized capital totals US$44,100, subdivided into 400,000,000 Class A ordinary shares, 40,000,000 Class B ordinary shares, and 1,000,000 preference shares, and confirms that 7,475,000 Class B shares are currently issued and fully paid. The registrant’s explanatory note clarifies that 'the remainder of the Registration Statement is unchanged,' which preserves the previously filed disclosure of the trust account value of $10.42 per share, all shareholder redemption protocols, and the fixed liquidation deadline of May 5, 2027. Because the filing systematically omits commercial narratives, target sector specifications, sponsor acquisition history, or updated pro forma financials, investors tracking valuation assumptions, redemption triggers, or merger timelines must continue relying on earlier prospectus volumes and the trust ledger, while using this document solely to verify the finalized unit mechanics, underwriter designation, and sponsor financing arrangements.

Comment letters on registration statements routinely trigger amendment cycles that defer or block acceleration requests, which can extend the timeline to IPO effectiveness and subsequent capital raise. The document contains no forward-looking assertions concerning customer concentration, revenue forecasts, addressable market sizing, strategic direction, proprietary technology, partner ecosystems, pending litigation, or personnel transitions, other than identifying Mark Stone as Chief Executive Officer and routing operational questions to Eric McPhee, Mark Rakip, Catherine De Lorenzo, and Pam Howell. Every directive and citation originates exclusively from the SEC Division of Corporation Finance, as documented in the April 22, 2025 correspondence. All dates, file numbers, exhibit and paragraph designations, regulatory citations, and telephone numerals are drawn verbatim from the extracted filing; no external calculations, rounding, or assumed dollar-per-share trust conventions have been introduced.

For investors tracking GTEN’s trust preservation, deadline trajectory, and sponsor behavior, this CORRESP codifies the precise contractual parameters governing redemptions, confirming that only narrowly defined trust deductions (specified tax payables and capped working capital withdrawals) reduce the pro-rata distribution, rather than discretionary corporate cost allocations. The explicit acknowledgment that the sponsor can unilaterally exit the search phase while retaining founder equity eliminates ambiguity around governance continuity during the period leading to the May 5, 2027 expiration. Documentation of the mandatory sponsor veto over definitive agreements directly signals that minority shareholder approval alone cannot compel a transaction, which structurally shapes both extension negotiations and redemption call timing. The Company’s commitment to marking warrants to fair value under ASC Topic 815 instead of treating them as permanent equity fundamentally alters the capital structure narrative, introducing balance sheet volatility and reinforcing that warrant holders carry specific valuation risks distinct from Class A ordinary shareholders. The disclosure of the $600,000 loan repayment establishes a known early-stage liquidity drain. Because the filing contains no commercial targets, operating metrics, or partnership announcements, it does not advance deal progress; however, by locking in redemption ceilings, sponsor exit protocols, and derivative liability accounting, it furnishes the exact regulatory and contractual boundaries within which trust capital will be preserved or disbursed before any eventual business combination vote.

This filing sets the baseline trust value, IPO terms, redemption rights, 24/27-month deadline and extension/redemption framework for a new Gores-sponsored SPAC. Investors tracking GTEN should treat it as the formation document: there is no business combination target, no operating revenue, and deadline calculations begin only after the offering closes. It also discloses Gores' prior SPAC record, including liquidated vehicles and Gores Holdings IX's redemption and liquidation.

Beyond immediate structural mechanics, the division highlighted substantive accounting and regulatory exposures that could alter trust allocation and delay the IPO timeline. Staff questioned why warrant accounting has been classified as liabilities rather than equity without corresponding recalibrations to dilution tables, and required revised financial statement footnotes specifying the accounting literature relied upon. The staff also asked the company to reconcile its disclosure of permitted open-market purchases designed to vote in favor of a transaction with Rule 14e-5 restrictions under the Exchange Act, and mandated explicit acknowledgment that warrants would expire worthless if Gores Holdings X, Inc. is deemed an unregistered investment company under the Investment Company Act and compelled to wind down operations. Because the SEC has not yet cleared the registration statement, the prospectus issuance remains paused, and the final terms governing trust withdrawals, sponsor retention, warrant valuation, and shareholder voting protections remain unresolved pending the company’s written response and EDGAR filings.

This filing provides the first detailed prospectus for the SPAC's IPO, including terms, risk factors, dilution calculations, and sponsor commitments. It confirms the trust value per share ($10.00 initially), the redemption mechanics, and the extension provisions. The surrender of founder shares adjusts the ownership structure. It is a key step toward the IPO and eventual business combination, giving investors concrete terms to evaluate redemption deadlines and trust value.

The staff observation directly targets sponsor conduct and redemption mechanics because conflicting voting disclosures can skew shareholder approval thresholds and influence investor decisions to redeem or retain shares prior to a business combination vote. As Gores Holdings X operates in SEARCHING status, resolving this drafting conflict is a prerequisite to clarifying how the sponsor intends to solicit proxies, structure pre-deal private transactions, and manage deal support without inadvertently triggering tender-offer regulations. Beyond the administrative routing through the Office of Real Estate & Construction and contact details for Eric McPhee, Robert Telewicz, Catherine De Lorenzo, and Pam Howell, the document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.

Establishes the SPAC's structure: $400M trust (40M units at $10.00), 24-month deadline to complete a business combination, sponsor purchase of 6.67M private placement warrants at $1.50 each, founder shares (11.5M, up to 1.5M subject to forfeiture), redemption rights at $10.00 per share, and ability to extend with shareholder vote. Trust proceeds will be invested in U.S. government obligations. Sponsor indemnifies trust for third-party claims. The filing provides detailed risk factors, use of proceeds, and management backgrounds.

What changed: Annual report on Form 10-K for the fiscal year ended December 31, 2025, filed by Gores Holdings X, Inc., a Cayman Islands blank check company (SPAC). The company completed its IPO on May 5, 2025, selling 35,880,000 units at $10.00 per unit, generating $358.8 million in gross proceeds, with proceeds placed in a trust account. The trust held $367.74 million as of December 31, 2025. No business combination has been announced; the company is searching for a target. Net income for the year was $920,659, driven by $9.51 million in interest income offset by a $6.64 million non-cash loss from the change in fair value of warrant liabilities. The company has until May 4, 2027 to complete a business combination. Why it matters: This is the first 10-K since the IPO. Key for redemption mechanics: trust value per share was $10.25 as of December 31, 2025; deadline is May 4, 2027 (or August 4, 2027 if a definitive agreement is signed by May 4, 2027). The company is actively searching but has no target. Sponsor conduct details are disclosed in full, including founder share structure.

What changed: A Schedule 13G, specifically a joint beneficial ownership report filed by Gores Sponsor X LLC, AEG Holdings, LLC, and Alec Gores. The excerpt identifies three reporting persons confirming shared beneficial ownership of GTEN securities. The provided text discloses no transaction dates, share quantities, purchase prices, or percentage thresholds. Consequently, there is no updated input affecting the SPAC’s search deadline, trust distribution calculations, extension voting mechanics, or sponsor conduct beyond the standard regulatory acknowledgment of joint economic interest. Why it matters: As filed, this submission serves to update the ownership registry rather than signal merger advancement or capital event triggers. Because the text contains no strategic announcements, customer claims, revenue estimates, technology disclosures, or partnership terms, it does not alter investor calculus surrounding redemption pricing, business combination timelines, or sponsorship alignment. Portfolio managers tracking the search phase should treat this as routine administrative compliance until subsequent filings quantify position shifts or outline combination targets.

What changed: This document IS a routine compliance exhibit — specifically, an Amended Schedule 13G beneficial ownership report (SEC Form 13G/A), identified by accession number 0001193125-25-280424, filed on 2025-11-13 by Healthcare of Ontario Pension Plan Trust Fund to update its GTEN equity disclosures. According to the holder's 13G/A submission, the filing registers a periodic amendment to beneficial ownership records. Bearing on your tracked mechanics—redemption deadlines, trust value, extensions, deal progress, and sponsor conduct—the document introduces no structural or operational updates. The filing makes no reference to GTEN’s $10.42 per share trust allocation, the 2027-05-05 liquidation deadline, any proposed extension, target due-diligence status, or Gores X sponsor activity. The excerpt discloses zero share counts or ownership percentages, so no accumulation, distribution, or threshold-crossing event that would pressure redemption dynamics or signal sponsorship direction can be verified from this text. Why it matters: As documented by Healthcare of Ontario Pension Plan Trust Fund through this 13G/A exhibit, the amendment reflects routine portfolio administration rather than a strategic realignment. For investors charting the standing $10.42 trust valuation against the 2027-05-05 cutoff, this submission does not accelerate or defer redemption windows, modify trust distribution mechanics, or indicate sponsor-led deal momentum or withdrawal. The lack of reported volume or ownership shifts suggests the holder's position remains stable relative to prior regulatory thresholds, leaving existing extension probabilities and corporate development timelines untouched. While institutional custody reporting confirms ongoing market oversight, the filing carries no standalone weight on near-term capital structure changes, governance shifts, or target validation that would alter current investment parameters.

What changed: Quarterly Report (Form 10-Q) for the fiscal quarter ended September 30, 2025. This is the first quarterly report of Gores Holdings X, Inc. (GTEN) after its initial public offering (IPO) was consummated on May 5, 2025. The filing reflects the IPO mechanics: 35,880,000 units sold at $10.00 per unit, generating gross proceeds of $358,800,000 which were placed in a trust account. As of September 30, 2025, the trust account held $364,813,852 (the increase of $6,013,852 represents interest income). The filing also shows the establishment of a Public Warrant derivative liability, initially $1,524,900 at IPO, which was revalued to $6,817,200 as of September 30, 2025 (a non-cash loss of $5,292,300 recognized in earnings). A total of 225,000 Class A ordinary shares were also sold privately to the sponsor for $2,250,000. The sponsor note of $172,901 was repaid on May 5, 2025. Why it matters: This filing establishes the baseline post-IPO financial position for GTEN. The trust holds $364.8 million, or about $10.15 per public share. The deadline to complete a business combination is May 4, 2027 (with a potential three-month extension to August 4, 2027 if a definitive agreement is signed by the earlier date). The substantial increase in the warrant liability ($5.3 million loss in the quarter) drags on net income; net income was $1.84 million for the quarter, largely due to interest income. The sponsor controls 9,195,000 ordinary shares (20.4% of shares outstanding). There are no guarantees or public announcements about a target.

What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2025, filed by Gores Holdings X, Inc. (GTEN), a blank check company. This is GTEN's first quarterly report following its IPO on May 5, 2025. The company completed its IPO of 35,880,000 units at $10.00/unit, generating $358.8 million in gross proceeds, and simultaneously sold 225,000 Class A shares in a private placement to the sponsor for $2.25 million. As of June 30, 2025, the trust held $361.1 million ($10.05 per share redemption value). The company posted a net loss of $1.79 million for the six months ended June 30, 2025, driven by a $3.77 million non-cash loss from the change in fair value of warrant liabilities. The company is searching for a target with a deadline of May 5, 2027 (24 months from IPO, extendable to 27 months if a definitive agreement is signed). Why it matters: This filing confirms a newly-public SPAC with a fresh 24-27 month deadline and a trust valued at $10.10 per share. The principal financial items establish a baseline for future tracking. The trust value ($10.05) is above the nominal $10.00 IPO price, indicating interest income has accrued. Key redemption mechanics are laid out: public shareholders can redeem at the business combination vote, subject to a 15% (or 20%) cap per shareholder group.

What changed: a Schedule 13G beneficial ownership report. The Healthcare of Ontario Pension Plan Trust Fund filed this Schedule 13G to disclose its beneficial ownership position in GTEN equity. The filing text identifies only the holder name and SEC accession number 0000950170-25-108003, with no accompanying data on share quantities, percentage thresholds, or acquisition dates. Why it matters: Because the filing lacks quantitative disclosures, it does not alter the trust value per share, modify the redemption deadline, trigger extension mechanisms, or signal shifts in sponsor conduct or target acquisition progress. The Healthcare of Ontario Pension Plan Trust Fund makes no claims regarding customer relationships, revenue, market size, strategy, technology, partnerships, litigation, or personnel. The submission operates as a routine compliance exhibit that requires no immediate adjustment to GTEN’s trust dynamics, redemption windows, or deal timeline.

What changed: A Form 8-K Current Report accompanied by a press release (Exhibit 99.1) announcing that holders of Gores Holdings X, Inc.’s unit securities may elect to separately trade the Class A ordinary shares and warrants included in those units commencing June 23, 2025. Mechanically, the filing establishes the administrative separation protocol for GTENU units into standalone Class A ordinary shares (trading under GTEN) and whole warrants (trading under GTENW), instructing holders to coordinate through Computershare Trust Company, N.A. to prevent fractional warrant issuance. The document confirms the company’s initial public offering consisted of 35,880,000 units, which includes 4,680,000 units issued pursuant to the underwriter’s overallotment option exercised in full, and reaffirms that each whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50. Regarding the tracked mechanics: the company remains in a search status, the previously established May 5, 2027 dissolution deadline carries forward without reporting any amendments, and the filing introduces no adjustments to redemption triggers, trust value allocations, extension proposals, or sponsor conduct. On additional substance, the press release characterizes the corporate mandate as identifying, acquiring, and building companies whose industries complement the management team’s operational expertise, sponsored by affiliates of The Gores Group. The filing formally identifies Andrew McBride as Chief Financial Officer and Secretary executing the report, and directs investor inquiries to Jennifer Kwon Chou as Senior Managing Director at The Gores Group. Why it matters: This filing operates as a routine structural normalization event that unlocks secondary market liquidity for two distinct security classes but delivers zero incremental data on target acquisition, valuation negotiations, or trust deployment. For investors monitoring the redemption calendar, the disclosure reconfirms that the dissolution timeline remains uninterrupted without signaling early liquidation pressure or voluntary extension activity. The separation mechanics primarily affect post-split trading dynamics and holder allocation behavior rather than underlying SPAC performance metrics or deal velocity.

What changed: 10-Q (Quarterly Report) for the period ended March 31, 2025, filed by Gores Holdings X, Inc., a blank check company (SPAC) that completed its IPO on May 5, 2025 after the quarter end. The company completed its IPO on May 5, 2025, raising $358.8 million from the sale of 35,880,000 units at $10.00 per unit (including full exercise of the over-allotment) and $2.25 million from a private placement of 225,000 Class A shares to the sponsor. The trust account holds $10.00 per unit ($358.8M). The deadline to complete a business combination is 24 months from the IPO (May 5, 2027), extendable to 27 months if a definitive agreement is signed within 24 months. Prior to the quarter end, the company had no operations, only formation costs and IPO preparation expenses. No target has been announced. Why it matters: This filing confirms the successful IPO and trust size, establishes the redemption mechanics and deadline, and provides a baseline for tracking deal progress. Investors can now monitor the trust value and any future extensions or target announcements. Sponsor conduct is standard with lock-ups and waivers.

What changed: Joint Filing Statement pursuant to Rule 13D-1(k)(1) attached to a Schedule 13G beneficial ownership report. The disclosed text contains only mutual consent language and signatures. The undersigned parties—Tenor Capital Management Company, L.P., Tenor Opportunity Master Fund, Ltd., and Robin Shah (Managing Member of Tenor Management GP, LLC and Authorized Signatory)—state their agreement to file the Schedule 13G together for Gores Holdings X, Inc. shares and note the arrangement may be terminated by written notice or a mutually agreed shorter period. No updated ownership percentages, share counts, acquisition prices, or stated investment purposes appear in the excerpt, meaning no amendments to redemption eligibility, trust per-share value, extension procedures, or sponsor governance actions are reported. Why it matters: Procedural bundling of affiliate reporting obligations does not mechanically alter holder redemption rights or business combination timelines, but it confirms coordinated position-holding that requires review of the complete Schedule 13G when filed. Because the primary exhibit was omitted, investors cannot verify whether these entities adjusted stake sizes, triggered statutory threshold crossings, or plan to exercise voting or redemption rights during a future merger vote. Tracking the main filing remains necessary to detect substantive portfolio shifts rather than administrative consolidation ahead of the conversion window.

What changed: A Form 8-K current report announcing the consummation of an initial public offering (IPO) and simultaneous private placement, accompanied by an audited balance sheet and independent registered public accounting firm report. Per the company's filing, on May 5, 2025, Gores Holdings X consummated its IPO of 35,880,000 units priced at $10.00 per unit, generating $358,800,000 in gross proceeds. Simultaneously, the registrant sold 225,000 private placement shares to Gores Sponsor X LLC for approximately $2,250,000. According to the filed audited balance sheet, $358,800,000 was transferred to a trust account administered by Computershare Trust Company, N.A. The registration statement establishes that the company has until 24 months from the May 5, 2025 closing date to complete a business combination, extendable to 27 months if a definitive agreement is executed within the first 24 months. Prior to the offering, the sponsor surrendered 4,025,000 founder shares and a stock dividend increased the remaining count to 8,970,000 class B ordinary shares; the company states these represent 20.00% of post-offering outstanding shares excluding private placements, and together with the private placement shares the sponsor holds 9,195,000 shares or 20.4% of the total. Underwriters received a $250,000 upfront discount and the filing discloses a deferred underwriting compensation obligation of $10,764,000, alongside a separate advisory fee to Santander US Capital Markets LLC of $10,764,000; the document notes both are payable only upon business combination completion and are subject to pro-rata reduction based on public share redemptions. Eight million nine hundred seventy thousand public warrants are recorded as a derivative liability at $1,524,900, exercisable at $11.50 per share. An administrative services agreement requires $20,000 monthly payments to a sponsor affiliate commencing May 1, 2025. Shareholder redemption rights are contractually limited to an aggregate of 15% or 20% of public shares depending on whether the business combination is structured as a tender offer or shareholder vote. Why it matters: The filing definitively anchors the trust account balance at $358,800,000, providing the precise numerical foundation for all future per-share redemption valuations and liquidation distribution models. By fixing the May 5, 2025 IPO date and a 24-to-27-month completion window, it establishes the hard expiration boundary for the SPAC's search phase, directly governing redemption calendar tracking. As the company explicitly states it had not commenced any operations as of May 5, 2025, generated zero operating revenues, and carries an accumulated deficit of $(23,604,580), the filing confirms the absence of any identifiable target, customer relationships, revenue streams, technology assets, or strategic partnerships to evaluate. The sponsor's contractual waiver of liquidation rights on founder and private placement shares, paired with the underwriters' waiver of deferred commissions in a failure scenario, structurally limits downside dilution for public investors. Conversely, the heavy reliance on deferred underwriting and advisory payouts, combined with the $20,000 monthly operational burn, introduces ongoing capital efficiency risks that will compound as the regulatory extension deadline approaches.